# Evaluation of Ivacaftor in Patients Using Ataluren for Nonsense Mutations

> **NCT03256799** · PHASE4 · COMPLETED · sponsor: **University of Alabama at Birmingham** · enrollment: 1 (actual)

## Conditions studied

- Cystic Fibrosis

## Interventions

- **DRUG:** Ivacaftor/Ataluren

## Key facts

- **NCT ID:** NCT03256799
- **Lead sponsor:** University of Alabama at Birmingham
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-03-17
- **Primary completion:** 2017-07-10
- **Final completion:** 2018-02-16
- **Target enrollment:** 1 (ACTUAL)
- **Last updated:** 2019-07-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03256799

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03256799, "Evaluation of Ivacaftor in Patients Using Ataluren for Nonsense Mutations". Retrieved via AI Analytics 2026-05-29 from https://api.ai-analytics.org/clinical/NCT03256799. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*